Cargando…

Biomarkers of inflammation in infants with cystic fibrosis

BACKGROUND: There are urgent needs for clinically relevant biomarkers to identify children with cystic fibrosis (CF) at risk for more progressive lung disease and to serve as outcome measures for clinical trials. Our objective was to investigate three targeted biomarkers in a population of asymptoma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laguna, Theresa A., Williams, Cynthia B., Nunez, Myra G., Welchlin-Bradford, Cole, Moen, Catherine E., Reilly, Cavan S., Wendt, Chris H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759377/ https://www.ncbi.nlm.nih.gov/pubmed/29310632 http://dx.doi.org/10.1186/s12931-017-0713-8

Ejemplares similares

Airway Microbiota in Bronchoalveolar Lavage Fluid from Clinically Well Infants with Cystic Fibrosis
por: Laguna, Theresa A., et al.
Publicado: (2016)

Inflammation and Airway Microbiota during Cystic Fibrosis Pulmonary Exacerbations
por: Zemanick, Edith T., et al.
Publicado: (2013)

Cystic fibrosis diagnosed by state newborn screening: Or is it?
por: Fox, Maura, et al.
Publicado: (2020)

Unexpected Height Loss in an Adolescent With Cystic Fibrosis
por: Schendel, Anne, et al.
Publicado: (2018)

Impaired Fasting Glucose in Cystic Fibrosis
por: Frohnert, Brigitte I., et al.
Publicado: (2010)

Inflammation in Cystic Fibrosis
Publicado: (1996)

Network Analysis to Identify Multi-Omic Correlations in the Lower Airways of Children With Cystic Fibrosis
por: O’Connor, John B., et al.
Publicado: (2022)

634. Chlorhexidine Oral Rinses to Alter the Oral and Sputum Microbiota in COPD (CLIMB): a Randomized, Double-blinded, Placebo-controlled, Parallel-group Pilot Study
por: Pragman, Alexa, et al.
Publicado: (2020)

Cystic Fibrosis Transmembrane Conductance Regulator Genotype, Not Circulating Catecholamines, Influences Cardiovascular Function in Patients with Cystic Fibrosis
por: Bisch, Alexander L, et al.
Publicado: (2019)

Atypical Presentation of Cystic Fibrosis in An Infant
por: Sahoo, Bandya, et al.
Publicado: (2022)

The Arginine Decarboxylase Pathways of Host and Pathogen Interact to Impact Inflammatory Pathways in the Lung
por: Paulson, Nick B., et al.
Publicado: (2014)

The Pathogenesis of Cystic Fibrosis and Progress Towards Gene Therapy
por: Stern, Myra, et al.
Publicado: (1999)

Acquired cystic fibrosis transmembrane conductance regulator dysfunction
por: Banks, Catherine, et al.
Publicado: (2018)

How Can We Target Pulmonary Inflammation in Cystic Fibrosis?
por: Greene, Catherine M.
Publicado: (2010)

Infection, inflammation and exercise in cystic fibrosis
por: van de Weert-van Leeuwen, Pauline Barbera, et al.
Publicado: (2013)

The Resolution Approach to Cystic Fibrosis Inflammation
por: Recchiuti, Antonio, et al.
Publicado: (2020)

Fungal Infection and Inflammation in Cystic Fibrosis
por: Poore, T. Spencer, et al.
Publicado: (2021)

Taking stock of gene therapy for cystic fibrosis
por: Stern, Myra, et al.
Publicado: (2000)

Detection and identification of fungi in the lower airway of children with and without cystic fibrosis
por: O’Connor, John B., et al.
Publicado: (2023)

IP-10 Is a Potential Biomarker of Cystic Fibrosis Acute Pulmonary Exacerbations
por: Solomon, George M., et al.
Publicado: (2013)

A New Era for Cystic Fibrosis and Cystic Fibrosis Transmembrane Conductance Regulator Modulator Trials in Infants
por: Wainwright, Claire E.
Publicado: (2022)

Antiproteases as Therapeutics to Target Inflammation in Cystic Fibrosis
por: Quinn, Derek J, et al.
Publicado: (2010)

New Developments in Cystic Fibrosis Airway Inflammation
por: Palaniyar, Nades, et al.
Publicado: (2015)

Cystic Fibrosis Inflammation: Hyperinflammatory, Hypoinflammatory, or Both?
por: Murphy, Sean V., et al.
Publicado: (2019)

Inflammation and Infection in Cystic Fibrosis: Update for the Clinician
por: Petrocheilou, Argyri, et al.
Publicado: (2022)

Longitudinal development of the airway microbiota in infants with cystic fibrosis
por: Ahmed, Bushra, et al.
Publicado: (2019)

Early respiratory viral infections in infants with cystic fibrosis
por: Deschamp, Ashley R., et al.
Publicado: (2019)

Asymptomatic case of Covid-19 in an infant with cystic fibrosis
por: Poli, Piercarlo, et al.
Publicado: (2020)

Anti-Inflammatory Influences of Cystic Fibrosis Transmembrane Conductance Regulator Drugs on Lung Inflammation in Cystic Fibrosis
por: Harwood, Kiera H., et al.
Publicado: (2021)

Islet Function in the Pathogenesis of Cystic Fibrosis-Related Diabetes Mellitus
por: Westholm, Efraim, et al.
Publicado: (2021)

Peptides in Bronchoalveolar Lavage in Chronic Obstructive Pulmonary Disease
por: Wendt, Chris H., et al.
Publicado: (2016)

Oxidative Stress Biomarkers in Cystic Fibrosis and Cystic Fibrosis-Related Diabetes in Children: A Literature Review
por: Pinzaru, Anca Daniela, et al.
Publicado: (2023)

Immunoreactive Trypsinogen in Infants Born to Women with Cystic Fibrosis Taking Elexacaftor–Tezacaftor–Ivacaftor
por: Patel, Payal, et al.
Publicado: (2023)

Inflammation and CFTR: might neutrophils be the key in cystic fibrosis?
por: Witko-Sarsat, V, et al.
Publicado: (1999)

Update of Faecal Markers of Inflammation in Children with Cystic Fibrosis
por: Lee, Jung M., et al.
Publicado: (2012)

The Role of Sphingolipids and Ceramide in Pulmonary Inflammation in Cystic Fibrosis
por: Becker, Katrin Anne, et al.
Publicado: (2010)

Mitochondrial Stress Responses and “Mito-Inflammation” in Cystic Fibrosis
por: Patergnani, Simone, et al.
Publicado: (2020)

Infection and Inflammation MUC up the Cystic Fibrosis Airway
por: Ma, Jonathan
Publicado: (2022)

Type 2 inflammation in cystic fibrosis: New insights
por: Manti, Sara, et al.
Publicado: (2022)

Ochrobactrum anthropi bacteremia in a preterm infant with cystic fibrosis
por: Menezes, Fernando Gatti, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_5ktfn47qo1sdako8rhk3br41nu